Picture of 2cureX AB logo

2CUREX 2cureX AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: 2cureX Gets Approval For Start Of Clinical Trial In Pancreatic Cancer

Nov 16 (Reuters) - 2cureX AB  2CUREX.ST :
    * THE UNIVERSITY HOSPITAL, VEJLE HOSPITAL AND 2CUREX HAVE RECEIVED APPROVAL TO START A
CLINICAL
TRIAL IN PANCREATIC CANCER
    * STUDY RESULTS TO BE COMPILED UP TO AND INCLUDING DEC 2023

Source text for Eikon:  ID:nWkrbbKbRD 
Further company coverage:  2CUREX.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on 2cureX AB

See all news